SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs >

Momenta Pharmaceuticals, Inc. (MNTA)

MNTA RSS Feed
Add MNTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/23/2017 11:46:17 AM - Followers: 173 - Board type: Free - Posts Today: 3
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MNTA
Current Price
Volume:
Bid Ask Day's Range
MNTA News: Statement of Changes in Beneficial Ownership (4) 05/12/2017 02:15:59 PM
MNTA News: Statement of Changes in Beneficial Ownership (4) 05/12/2017 02:15:05 PM
MNTA News: Statement of Changes in Beneficial Ownership (4) 05/12/2017 02:14:39 PM
MNTA News: UPDATE -- Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences 05/10/2017 04:05:00 PM
MNTA News: Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences 05/10/2017 08:00:00 AM
PostSubject
#17095  Sticky Note The M923 phase-3 trial has already finished, for DewDiligence 04/13/17 06:10:07 PM
#17262   Curious about why you didn't hold out for rwwine 05/23/17 11:46:17 AM
#17261   I sold most early yesterday as MNTA has biotech_researcher 05/23/17 11:06:08 AM
#17260   If I understood Wheeler correctly, there are planned biopearl 05/23/17 09:42:11 AM
#17259   True, but I wonder how confident MNTA is jmkobers 05/22/17 09:00:00 PM
#17258   This new job description implies they are working floblu14 05/22/17 07:53:50 PM
#17257   Mylan has always said it's right around the jbog 05/22/17 02:15:16 PM
#17256   Mylan approval coming next month alternatepatel 05/22/17 01:11:49 PM
#17255   any recent comments made by Mylan on their alternatepatel 05/22/17 01:01:01 PM
#17251   Momenta downgraded to Equal Weight from Overweight at Barclays jbog 05/22/17 07:22:01 AM
#17250   declaring Momenta the sole winner alternatepatel 05/21/17 02:01:05 AM
#17249   Alternatepatel, Yesterday was the final day for comments regarding jbog 05/20/17 01:42:39 PM
#17248   I differ. alternatepatel 05/20/17 02:32:08 AM
#17247   It has been explained on this board the jbog 05/19/17 12:40:40 PM
#17246   Unfortunate decision for Shire by Shire. alternatepatel 05/19/17 12:30:12 PM
#17245   At this point I don't believe Momenta would jbog 05/18/17 03:28:12 PM
#17244   If Momenta had the only apparently interchangeable Humira, marthambles 05/18/17 12:36:03 PM
#17243   $1.5b is too cheap for the only jbog 05/18/17 06:46:22 AM
#17242   1. $1.5b is too cheap for the only alternatepatel 05/18/17 12:23:53 AM
#17241   FLO, Hasn't WHEN always been the question. jbog 05/17/17 02:37:08 PM
#17240   if anyone desired they could buy the whole jbog 05/17/17 01:53:32 PM
#17239   Scott M. Storer at the tail end of floblu14 05/17/17 01:50:39 PM
#17238   Partnership or Buyout? alternatepatel 05/17/17 01:07:52 PM
#17237   I don't know, but probably not soon inasmuch DewDiligence 05/17/17 12:57:36 PM
#17236   Lovenox program alternatepatel 05/17/17 12:54:04 PM
#17235   MNTA 2017-2018 News Flow DewDiligence 05/16/17 07:10:59 PM
#17234   ABBV’s ‘135 Humira patent invalidated by USPTO: DewDiligence 05/16/17 07:08:09 PM
#17233   I would say an M923 partnership is more DewDiligence 05/15/17 02:25:27 PM
#17232   Hi Dew, I see this much more valuable rwwine 05/15/17 01:53:30 PM
#17231   MNTA ReadMeFirst DewDiligence 05/14/17 06:21:42 PM
#17230   I don't agree. Cash received in advance of DewDiligence 05/14/17 12:19:39 PM
#17229   not counting the “deferred revenue” line, which is jbog 05/14/17 08:10:16 AM
#17228   MNTA’s 3/31/17 pro forma cash balance was $470.9M—a DewDiligence 05/13/17 05:08:46 PM
#17227   MNTA 2017-2018 News Flow DewDiligence 05/13/17 04:57:05 PM
#17226   You're right—the Lovenox patent-infringement case has a trial DewDiligence 05/13/17 04:54:57 PM
#17225   But but this is not the damages suit biopearl 05/13/17 04:46:01 PM
#17224   MNTA had 81.1M diluted shares for valuation purposes DewDiligence 05/13/17 04:43:40 PM
#17223   Please see #msg-130845072. Regards, Dew DewDiligence 05/13/17 04:06:40 PM
#17222   Dew, is the update re lovonox litigation date biopearl 05/13/17 03:36:04 PM
#17221   I give Momenta better than 50-50 odds that jbog 05/12/17 12:07:54 PM
#17220   ABBV's '135 patent is pretty important insofar it DewDiligence 05/12/17 09:36:13 AM
#17219   How big a difference would that make? I alternatepatel 05/12/17 01:15:09 AM
#17218   Global revenues of Copaxone® (20 mg/mL and 40 jbog 05/11/17 07:43:55 AM
#17217   My timeline says “2017?” —so I'm covered regardless DewDiligence 05/10/17 07:39:38 PM
#17216   Pfizer last week talked about their "Hospira" plant jbog 05/10/17 06:24:55 PM
#17215   MNTA 2017-2018 News Flow DewDiligence 05/10/17 03:59:16 PM
#17214   Typo: May 16 is a Tuesday. DewDiligence 05/10/17 09:23:04 AM
#17213   Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming floblu14 05/10/17 08:09:46 AM
#17212   so another 10m+ - to go.? t57 05/08/17 12:09:00 PM
#17211   In April 2015, the Company entered into an jbog 05/08/17 07:45:50 AM
#17209   I commented on your question in #msg-128758822. Although DewDiligence 05/07/17 08:03:48 PM
PostSubject